Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Rockwell Medical (RMTI) Interest & Investment Income (2016 - 2025)

Historic Interest & Investment Income for Rockwell Medical (RMTI) over the last 16 years, with Q3 2025 value amounting to $55000.0.

  • Rockwell Medical's Interest & Investment Income rose 8333.33% to $55000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $219000.0, marking a year-over-year increase of 10857.14%. This contributed to the annual value of $92000.0 for FY2024, which is 5639.81% down from last year.
  • As of Q3 2025, Rockwell Medical's Interest & Investment Income stood at $55000.0, which was up 8333.33% from $69000.0 recorded in Q2 2025.
  • Over the past 5 years, Rockwell Medical's Interest & Investment Income peaked at $69000.0 during Q2 2025, and registered a low of -$6000.0 during Q3 2022.
  • Moreover, its 5-year median value for Interest & Investment Income was $36000.0 (2023), whereas its average is $34562.5.
  • Per our database at Business Quant, Rockwell Medical's Interest & Investment Income tumbled by 9356.73% in 2021 and then surged by 103333.33% in 2023.
  • Rockwell Medical's Interest & Investment Income (Quarter) stood at $5000.0 in 2021, then skyrocketed by 760.0% to $43000.0 in 2022, then fell by 2.33% to $42000.0 in 2023, then crashed by 30.95% to $29000.0 in 2024, then soared by 89.66% to $55000.0 in 2025.
  • Its Interest & Investment Income was $55000.0 in Q3 2025, compared to $69000.0 in Q2 2025 and $66000.0 in Q1 2025.